Glucagon-Like Peptide-1 Receptor Agonist Prevented the Progression of Hepatocellular Carcinoma in a Mouse Model of Nonalcoholic Steatohepatitis

Glucagon-like peptide-1 (GLP-1) receptor agonists are used to treat diabetes, but their effects on nonalcoholic steatohepatitis (NASH) and the development of hepatocellular carcinoma (HCC) remain unclear. In this study, mice with streptozotocin- and high-fat diet-induced diabetes and NASH were subcu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Kojima, Motoyasu, Takahashi, Hirokazu, Kuwashiro, Takuya, Tanaka, Kenichi, Mori, Hitoe, Ozaki, Iwata, Kitajima, Yoichiro, Matsuda, Yayoi, Ashida, Kenji, Eguchi, Yuichiro, Anzai, Keizo
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7460814/
https://ncbi.nlm.nih.gov/pubmed/32785012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21165722
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados